QUESTRAN

This brand name is authorized in Australia, Brazil, Germany, Estonia, Finland, France, Ireland, Japan, Netherlands, New Zealand, United Kingdom, United States, South Africa

Active ingredients

The drug QUESTRAN contains one active pharmaceutical ingredient (API):

1 Colestyramine UNII 4B33BGI082 - CHOLESTYRAMINE

Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels. Read about Colestyramine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
QUESTRAN Powder for oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AC01	Colestyramine	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2967E, 9249T
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505105101136318, 562620060000717
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00869146, 04370366
Country: EE	Ravimiamet	Identifier(s): 1123513, 1510535, 1605271, 1753961
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 160531
Country: FR	Base de données publique des médicaments	Identifier(s): 65691327
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 32654
Country: IE	Health Products Regulatory Authority	Identifier(s): 44329, 55591
Country: JP	医薬品医療機器総合機構	Identifier(s): 2189009R1032
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62820, 62839
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1208
Country: US	FDA, National Drug Code	Identifier(s): 49884-936, 49884-937
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/7.5/39